94 related articles for article (PubMed ID: 8172533)
21. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
22. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
23. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.
Minaguchi T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
Cancer Res; 1998 Oct; 58(20):4585-6. PubMed ID: 9788606
[TBL] [Abstract][Full Text] [Related]
24. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
[TBL] [Abstract][Full Text] [Related]
25. Analysis of FHIT transcripts in cervical and endometrial cancers.
Su TH; Wang JC; Tseng HH; Chang CP; Chang TA; Wei HJ; Chang JG
Int J Cancer; 1998 Apr; 76(2):216-22. PubMed ID: 9537583
[TBL] [Abstract][Full Text] [Related]
26. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
29. HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA.
Chu TY; Shen CY; Chiou YS; Lu JJ; Perng CL; Yu MS; Liu HS
Int J Cancer; 1998 Jan; 75(2):199-204. PubMed ID: 9462708
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women.
Das BC; Gopalkrishna V; Das DK; Sharma JK; Singh V; Luthra UK
Cancer; 1993 Jul; 72(1):147-53. PubMed ID: 8389665
[TBL] [Abstract][Full Text] [Related]
31. Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix.
Herrington CS; Worsham M; Southern SA; Mackowiak P; Wolman SR
Mol Pathol; 2001 Jun; 54(3):160-4. PubMed ID: 11376128
[TBL] [Abstract][Full Text] [Related]
32. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the p53 gene and papillomavirus detection in smears from cervical lesions.
dos Santos Oliveira Ldo H; Fernandez Ade P; Xavier BL; Machado Rodrigues Ede V; Cavalcanti SM
Sao Paulo Med J; 2002 Jan; 120(1):20-2. PubMed ID: 11836549
[TBL] [Abstract][Full Text] [Related]
34. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
Zhao W; Si J; Li K
Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):654-7. PubMed ID: 8745488
[TBL] [Abstract][Full Text] [Related]
35. [The detection of p53 gene and HPV16 oncogene in cervical carcinoma].
Sun Y; Si L
Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):29-32. PubMed ID: 7781112
[TBL] [Abstract][Full Text] [Related]
36. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
37. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
38. Telomerase, p53 and human papillomavirus infection in the uterine cervix.
Nair P; Jayaprakash PG; Nair MK; Pillai MR
Acta Oncol; 2000; 39(1):65-70. PubMed ID: 10752656
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer.
Lu X; Feki A
Int J Gynecol Cancer; 2006; 16(2):708-17. PubMed ID: 16681751
[TBL] [Abstract][Full Text] [Related]
40. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]